Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v8-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-11-28 | 2023-11-28 |
| Drug Identification Number | 02229418 | 02229418 |
| Brand name | NAROPIN | NAROPIN |
| Common or Proper name | ropivacaine HCl 10mg/mL 5x10mL SU Polyamp® Duofit® | ropivacaine HCl 10mg/mL 5x10mL SU Polyamp® Duofit® |
| Company Name | ASPEN PHARMACARE CANADA INC. | ASPEN PHARMACARE CANADA INC. |
| Ingredients | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | EPIDURAL EPIDURAL | EPIDURAL EPIDURAL |
| Packaging size | 5 PP Polybag | 5 PP Polybag |
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | ||
| Actual start date | 2023-07-27 | 2023-07-27 |
| Estimated end date | 2023-12-31 | 2023-12-31 |
| Actual end date | 2023-11-21 | 2023-11-21 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | VR89863CA1 NAROPIN 10MG/ML LIQ PP AMP 5X10ML CA ASP | VR89863CA1 NAROPIN 10MG/ML LIQ PP AMP 5X10ML CA ASP |
| Health Canada comments |